This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (23)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Ophthalmol. 1998;116:679-680.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Latanoprost is a topical ocular hypotensive medication (prostaglandin F₂ analog) that is used for the reduction of intraocular pressure (IOP) in patients with glaucoma.

To our knowledge, an association between cystoid macular edema (CME) and the use of latanoprost in patients with glaucoma has not been investigated nor reported in the literature. We report 2 cases of patients with glaucoma who were diagnosed as having CME after 1 month of treatment with latanoprost.

Report of Cases

Case 1

An 83-year-old woman with primary open-angle glaucoma was seen in the clinic in 1995. The patient underwent cataract extraction with phacoemulsification of the right eye, complicated by a posterior capsular tear and prolapsed vitreous that requiredi anterior vitrectomy and anterior chamber intraocular lens placement.

Over the next year, there was increasing difficulty in controlling the patient's IOPs, and eventually latanoprost was added to her therapeutic regimen. She was prescribed latanaprost eyedrops every night, in addition to 5% . . . [Full Text of this Article]

Case 2

Comment
Reprints: Patrick J. Butler, Prairie Eye Center, 2020 W Iles Ave, Springfield, IL 62704.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?